Division of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Division of Nephrology and Hypertension, University of Cape Town, Cape Town, South Africa.
PLoS One. 2022 Jun 10;17(6):e0269839. doi: 10.1371/journal.pone.0269839. eCollection 2022.
Indigenous people represent approximately 5% of the world's population. However, they often have a disproportionately higher burden of cardiovascular disease (CVD) risk and chronic kidney disease (CKD) than their equivalent general population. Several non-pharmacological interventions (e.g., educational) have been used to reduce CVD and kidney disease risk factors in Indigenous groups. The aim of this paper is to describe the protocol for a scoping review that will assess the impact of non-pharmacological interventions carried out in Indigenous and remote dwelling populations to reduce CVD risk factors and CKD.
This scoping review will be guided by the methodological framework for conducting scoping studies developed by Arksey and O'Malley. Both empirical (Medline, Embase, Cochrane Library, CINAHL, ISI Web of Science and PsycINFO) and grey literature references will be assessed if they focused on interventions targeted at reducing CVD or CKD among Indigenous groups. Two reviewers will independently screen references in consecutive stages of title/abstract screening and then full-text screening. Impact of interventions used will be assessed using the reach, effectiveness, adoption, implementation, maintenance (RE-AIM) framework. A descriptive overview, tabular summaries, and content analysis will be carried out on the extracted data.
This review will collect and analyse evidence on the impact of interventions of research carried out to reduce CVD and CKD among Indigenous populations. Such evidence will be disseminated using traditional approaches that includes open-access peer-reviewed publication, scientific presentations, and a report. Also, we will disseminate our findings to the government and Indigenous leaders. Ethical approval will not be required for this scoping review as the data used will be extracted from already published studies with publicly accessible data.
原住民约占世界人口的 5%。然而,他们患心血管疾病(CVD)和慢性肾脏病(CKD)风险的比例往往高于其相应的一般人群。已经使用了几种非药物干预措施(例如教育)来降低原住民群体的 CVD 和肾脏病风险因素。本文的目的是描述一项范围综述的方案,该综述将评估在原住民和偏远地区居民中实施的非药物干预措施对降低 CVD 风险因素和 CKD 的影响。
本范围综述将遵循 Arksey 和 O'Malley 制定的进行范围研究的方法框架。如果参考资料集中于针对原住民群体的 CVD 或 CKD 干预措施,则将评估其经验(Medline、Embase、Cochrane 图书馆、CINAHL、ISI Web of Science 和 PsycINFO)和灰色文献参考资料。两名评审员将独立筛选标题/摘要筛选和全文筛选的连续阶段的参考文献。使用可达性、有效性、采用、实施、维持(RE-AIM)框架评估干预措施的影响。将对提取的数据进行描述性概述、表格摘要和内容分析。
本综述将收集和分析有关旨在降低原住民人群 CVD 和 CKD 风险的干预措施的影响的证据。此类证据将通过传统方法传播,包括开放获取同行评审出版物、科学演讲和报告。我们还将向政府和原住民领导人传播我们的研究结果。由于本范围综述将使用已经发表的研究数据,因此不需要伦理批准。